Fortrea Holdings Inc. (FTRE) Upgraded to Overweight at Barclays

Market Context

Fortrea Holdings Inc. operates in the Healthcare sector. The stock currently trades at $20.78 with a market capitalization of $1.4B. The stock has gained 119.9% over the past 52 weeks.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Barclays's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Fortrea Holdings Inc.

Among the 10 most recent ratings: 5 Buy, 5 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 06, 2026	Barclays	Overweight	N/A
Sep 30, 2026	UBS	Neutral	N/A
Aug 04, 2026	TD Cowen	Buy	N/A
Jul 31, 2026	Citigroup	Buy	N/A
Jul 30, 2026	Truist Securities	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View FTRE Stock Page